Page last updated: 2024-09-05

sb 203580 and Antiphospholipid Syndrome

sb 203580 has been researched along with Antiphospholipid Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguirre, MA; Barbarroja, N; Buendía, P; Cuadrado, MJ; Khamashta, M; López-Pedrera, C; Torres, LA; Velasco, F	1

Other Studies

1 other study(ies) available for sb 203580 and Antiphospholipid Syndrome

Article	Year
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:11 Topics: Adolescent; Adult; Aged; Antiphospholipid Syndrome; Cells, Cultured; Enzyme Inhibitors; Female; Gene Expression Regulation; Humans; Imidazoles; Male; MAP Kinase Signaling System; Middle Aged; Monocytes; p38 Mitogen-Activated Protein Kinases; Pyridines; Thromboplastin; Thrombosis; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1	2006

Article

Year

Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.

Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:11

Topics: Adolescent; Adult; Aged; Antiphospholipid Syndrome; Cells, Cultured; Enzyme Inhibitors; Female; Gene Expression Regulation; Humans; Imidazoles; Male; MAP Kinase Signaling System; Middle Aged; Monocytes; p38 Mitogen-Activated Protein Kinases; Pyridines; Thromboplastin; Thrombosis; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2006